Human placental cells and SARS-CoV-2 infection
Author Information
Author(s): Yoshida Nagisa, Thomas Jake R., Appios Anna, Brember Matthew P., Aye Irving L.M.H., Edgar James R., Firth Andrew E., Chung Betty Y.W., McGovern Naomi, Stewart Hazel
Primary Institution: University of Cambridge
Hypothesis
Are human placental cells resistant to SARS-CoV-2 infection and replication?
Conclusion
Primary trophoblast cells show minimal susceptibility to SARS-CoV-2 infection, which helps explain the low rates of vertical transmission.
Supporting Evidence
- ACE2 transcripts are found in various placental cell types, but protein expression does not significantly change across gestation.
- Only 0.5% of term trophoblast cells can be infected with SARS-CoV-2.
- Primary trophoblast cells poorly support viral release, while JEG-3 cells allow higher levels of viral release.
Takeaway
The study found that only a tiny fraction of placental cells can get infected by the virus, which helps protect the baby during pregnancy.
Methodology
The study used single-cell RNA sequencing and in vitro infection assays to analyze placental cells.
Limitations
The study's small sample size and lack of consideration for ACE2 splice variants may limit the findings.
Participant Demographics
Healthy women with normal pregnancies undergoing elective first trimester terminations.
Statistical Information
P-Value
0.5±0.15 %
Statistical Significance
p<0.05
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website